Grace Therapeutics
GRCE
#9721
Rank
A$82.11 M
Marketcap
A$5.31
Share price
-2.05%
Change (1 day)
-11.63%
Change (1 year)

Earnings for Grace Therapeutics (GRCE)

Earnings in 2025 (TTM): -A$14.8 Million

According to Grace Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$24.41 Million, an increase over its 2023 earnings that were of -A$72.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Grace Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$14.8 Million-39.37%
2024 -A$24.41 Million-66.16%
2023 -A$72.12 Million161.72%
2022 -A$27.56 Million60.58%
2021 -A$17.16 Million-462.11%
2020 A$4.73 M
2018 -A$37.33 Million
2015 -A$6.06 Million
2013 -A$14.72 Million49.55%
2012 -A$9.85 Million